Compare ANL & RCON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Recon Technology Ltd is an oilfield service company. The company is engaged in the sale of oilfield automation products, equipment for oil and gas production and transportation, and engineering services. It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. Majority of the firm's revenue comes from the Automation Product and Software segment.